Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium

被引：75
作者：
Groom, K. M. [1 ]
Ganzevoort, W. [2 ]
Alfirevic, Z. [3 ]
Lim, K. [4 ]
Papageorghiou, A. T. [5 ,6 ]
机构：
[1] Univ Auckland, Liggins Inst, Auckland, New Zealand
[2] Acad Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands
[3] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England
[4] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada
[5] St Georges Univ London, Fetal Med Unit, London, England
[6] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England
来源：
ULTRASOUND IN OBSTETRICS & GYNECOLOGY | 2018年 / 52卷 / 03期
关键词：
D O I：
10.1002/uog.19186
中图分类号：
O42 [声学];
学科分类号：
070206 ; 082403 ;
摘要：
[No abstract available]
引用
收藏
页码：295 / 296
页数：2
相关论文
共 10 条
  • [1] Alfirevic Z, 2016, STRIDER UK RANDOMIZE, DOI [10.5281/zenodo.56153, DOI 10.5281/ZENODO.56153]
  • [2] Ganzevoort W, 2016, DUTCH STRIDER SILDEN, DOI [10.5281/zenodo.56148, DOI 10.5281/ZENODO.56148]
  • [3] STRIDER: Sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction - A protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis
    Ganzevoort W.
    Alfirevic Z.
    von Dadelszen P.
    Kenny L.
    Papageorghiou A.
    van Wassenaer-Leemhuis A.
    Gluud C.
    Mol B.W.
    Baker P.N.
    [J]. Systematic Reviews, 3 (1)
  • [4] Groom KM, 2016, STRIDER NZAUS RANDOM, DOI [10.5281/zenodo.56150, DOI 10.5281/ZENODO.56150]
  • [5] Lim KI, 2016, STRIDER CANADA RANDO, DOI [10.5281/zenodo.56152, DOI 10.5281/ZENODO.56152]
  • [6] Sildenafil During Pregnancy A Preclinical Meta-Analysis on Fetal Growth and Maternal Blood Pressure
    Paauw, Nina D.
    Terstappen, Fieke
    Ganzevoort, Wessel
    Joles, Jaap A.
    Gremmels, Hendrik
    Lely, A. Titia
    [J]. HYPERTENSION, 2017, 70 (05) : 998 - +
  • [7] STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials
    Pels, A.
    Kenny, L. C.
    Alfirevic, Z.
    Baker, P. N.
    von Dadelszen, Peter
    Gluud, C.
    Kariya, C. T.
    Mol, B. W.
    Papageorghiou, A. T.
    van Wassenaer-Leemhuis, A. G.
    Ganzevoort, W.
    Groom, K. M.
    [J]. BMC PREGNANCY AND CHILDBIRTH, 2017, 17
  • [8] Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial
    Sharp, Andrew
    Cornforth, Christine
    Jackson, Richard
    Harrold, Jane
    Turner, Mark A.
    Kenny, Louise C.
    Baker, Philip N.
    Johnstone, Edward D.
    Khalil, Asma
    von Dadelszen, Peter
    Papageorghiou, Aris T.
    Alfirevic, Zarko
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (02) : 93 - 102
  • [9] Sildenafil citrate therapy for severe early-onset intrauterine growth restriction
    von Dadelszen, P.
    Dwinnell, S.
    Magee, L. A.
    Carleton, B. C.
    Gruslin, A.
    Lee, B.
    Lim, K. I.
    Liston, R. M.
    Miller, S. P.
    Rurak, D.
    Sherlock, R. L.
    Skoll, M. A.
    Wareing, M. M.
    Baker, P. N.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 118 (05) : 624 - 628
  • [10] Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction
    Wareing, M
    Myers, JE
    O'Hara, M
    Baker, PN
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) : 2550 - 2555
1